# Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

> **NCT01690520** · PHASE2 · COMPLETED · sponsor: **Nohla Therapeutics, Inc.** · enrollment: 163 (actual)

## Conditions studied

- Acute Biphenotypic Leukemia
- Acute Lymphoblastic Leukemia in Remission
- Acute Myeloid Leukemia in Remission
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Cyclosporine
- **BIOLOGICAL:** Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion
- **DRUG:** Fludarabine Phosphate
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Thiotepa
- **RADIATION:** Total-Body Irradiation
- **PROCEDURE:** Umbilical Cord Blood Transplantation

## Key facts

- **NCT ID:** NCT01690520
- **Lead sponsor:** Nohla Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-11
- **Primary completion:** 2018-09-18
- **Final completion:** 2020-05-29
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2021-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01690520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01690520, "Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01690520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*